You are here: Industry Insights > API

News List

Archimica’s $1.4 Million Manufacturing Expansion americanpharmaceuticalreview
July 23, 2021
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company′s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
RBI bulletin calls for diversification of pharma raw material imports, increasing pharma R&D spends expresspharma
July 16, 2021
Apart from securing own supply chain, the country can also use the pandemic to elevate the sector's position in the global supply chain by standing as a reliable exporter of pharmaceuticals, it said.
Purisys Obtains Two Global ISO Certifications contractpharma
July 09, 2021
Now certified for ISO 17025 for Testing and Calibration Laboratories and ISO 17034 for Reference Material Producers.
WuXi STA to build second US pharma manufacturing site at Middletown cphi-online
June 30, 2021
Facility is expected to come online in 2024 and will feature testing laboratories, manufacture of active pharmaceutical ingredients and manufacture and packaging of solid dosage pharmaceuticals and sterile products.
Lonza Expands API Development, Mfg. Facility in China contractpharma
June 29, 2021
?Lonza is investing CHF 20 million in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China.
Novasep Upgrades API Manufacturing Facility contractpharma
June 28, 2021
Novasep, a supplier of services and technologies for the life sciences industry, is investing $7.3 million at its Mourenx site in France to modernize the API manufacturing facility.
Global API market to value $300 billion by 2030 europeanpharmaceuticalreview
June 25, 2021
Researchers anticipate the growth of the aging population and rising investment in biologic drugs to promote the expansion of the global active pharmaceutical ingredient (API) market.
PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics: ICRA expresspharma
June 18, 2021
The production-linked incentive (PLI) schemes announced by the Government of India (GoI) for key raw materials such as bulk drugs and formulations, with a total incentive outlay of Rs. 210 billion will help the country become Aatmanirbhar.
Monosodium Phosphate 2-hydrate is now available with CEP cphi-online
June 17, 2021
Dr. Paul Lohmann? recently received a CEP (Certificate of Suitability to the European Pharmacopoeia) for Monosodium Phosphate 2-hydrate, which enables a customer to register a drug in several countries in a cost-saving and simplified way.
Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch cphi-online
June 15, 2021
Drug categories impacted by travel restrictions expected to see higher sales levels in FY22